Patent ID: 8226959
Filing Date: 2012-07-24
Classification: A61K,A61P

Abstract:
1. A method for the treatment or prevention of an allergic airways disease in a subject, the method comprising administering to the subject an effective amount of a Streptococcus pneumoniae capsular polysaccharide and a Streptococcus pneumoniae exotoxin or exotoxoid; wherein the capsular polysaccharide is the type 3 polysaccharide (T3P); the exotoxin or exotoxoid is pneumolysin or pneumolysoid (Ply); and the allergic airways disease is selected from asthma, asthma exacerbations, eosinophilic bronchitis, allergic rhinitis, chronic cough, sinusitis, angioedema, urticaria, chronic obstructive pulmonary disease, conjunctivitis and hay fever.